Skip to main content
International Journal of Women's Health logoLink to International Journal of Women's Health
. 2026 Apr 16;18:586268. doi: 10.2147/IJWH.S586268

Causal Relationship Between 38 Dietary Factors, Including Sugar and Alcohol Intakes, and Polycystic Ovary Syndrome: A Two-Sample Mendelian Randomization Study

Le Xu 1, Sa Zhang 1, Wanting Shi 1, Shien Zou 1,
PMCID: PMC13096030  PMID: 42022860

Abstract

Purpose

Emerging evidence suggests that diets high in sugar consumption may be implicated in the development of polycystic ovary syndrome (PCOS), but the causal nature of these associations remains unclear. This study aimed to explore the potential causal links between 38 specific dietary factors (including alcohol and added sugar), particularly sugar-sweetened beverage intake, and the risk of PCOS.

Patients and Methods

A two-sample Mendelian randomization (MR) approach was employed using genome-wide association study summary statistics. The inverse-variance weighted (IVW) method served as the primary analytical tool, with supplementary assessments conducted using the weighted median, weighted mode, and MR-Egger regression methods. Cochran’s Q test evaluated heterogeneity, while MR-Egger regression and MR pleiotropy residual sum and outlier (MR-PRESSO) analysis were applied to detect horizontal pleiotropy. Robustness of findings was further assessed through leave-one-out analysis, along with visualization via forest and funnel plots.

Results

The IVW analysis indicated potential causal associations between PCOS and alcohol intake frequency (OR = 1.39, 95% CI: 1.03–1.88, P = 0.03) and sugar added to tea (OR = 0.43, 95% CI: 0.21–0.89, P = 0.022); these associations were only supported by the IVW method and not by the other MR methods. No significant associations were observed for the 36 other dietary factors. For all 38 dietary factors, the sensitivity analyses confirmed that the results were not driven by individual instrumental variables, no significant heterogeneity was observed using Cochran’s Q test, and MR-Egger regression and MR-PRESSO detected no evidence of horizontal pleiotropy or outliers.

Conclusion

Genetically predicted alcohol intake frequency was causally associated with PCOS. Although the initial hypothesis considered added sugar as a potential risk factor, the observed protective association of “sugar in tea” could reflect a proxy effect of tea consumption itself rather than a direct benefit of sugar. Further population-based studies are warranted for validation.

Keywords: polycystic ovary syndrome, dietary factors, sugar intake, alcohol intake, tea, mendelian randomization, causal association, genome-wide association studies

Introduction

Polycystic ovary syndrome (PCOS) imposes health burdens on women of reproductive age, featuring hyperandrogenism, menstrual irregularities, and polycystic ovarian morphology.1 The global prevalence of PCOS is estimated at 10% to 13% of women when using the Rotterdam criteria.2 A PCOS prevalence of 5.6% to 8.6% was determined among Chinese women of 20–44 years of age.3 Beyond reproductive impacts, women with PCOS exhibit an elevated risk of metabolic disturbances,4 including insulin resistance, dyslipidemia, and obesity.5 Furthermore, the psychological impact of PCOS, encompassing depression, anxiety, and diminished quality of life, underscores the profound psychosocial burden experienced by affected individuals.6 The risk factors of PCOS comprise genetic predisposition,7,8 excessive exposure of the female fetus to androgens, maternal obesity and smoking,9 and exposure to environmental factors that may affect reproductive and metabolic functions.10

In addition to the recognized risk factors for PCOS, some evidence highlighted the possible role of sugar-sweetened beverages as a risk factor for PCOS.11–14 Sugar-sweetened beverage intake represents a significant dietary concern globally due to its high sugar content and potential adverse health effects.15,16 In 2019, China’s annual production of sugar-sweetened beverages reached 177.6 million tons.17 Consumption among children aged 8 to 14 also increased significantly, with daily volume doubling from 1998 to 2008.17 The high glycemic load from frequent sugar-sweetened beverage consumption can lead to insulin resistance, a key component in the pathogenesis of several metabolic syndromes.18 This insulin dysregulation can exacerbate the hormonal imbalances central to PCOS, promoting hyperandrogenism, which can worsen the clinical manifestations of the syndrome.19 In addition, sugar-sweetened beverage intake contributes to adiposity due to their high caloric density and low satiety, potentially exacerbating conditions such as PCOS, where weight management is crucial for symptom management.20 A population-based study from Brazil also indicated a positive correlation between the PCOS prevalence and sugar-sweetened beverage consumption.13 Conversely, a longitudinal prospective cohort study found that lower sugar-sweetened beverage consumption was associated with higher odds of PCOS in Black women.21 Furthermore, besides sugar-sweetened beverages, diets rich in carbohydrates and fat, low in fiber, and with a high glycemic index and glycemic load (ie., Western diets in general) are positively associated with PCOS risk.22,23

Alcohol can disrupt both endocrine regulation and metabolic homeostasis through multiple mechanisms along the hypothalamic-pituitary-ovarian (HPO) axis. Experimental and clinical data suggest that alcohol interferes with hypothalamic gonadotropin‑releasing hormone (GnRH) pulsatility, leading to altered secretion of luteinizing hormone and follicle‑stimulating hormone. This dysregulation can impair follicular development, ovulation, and luteal function, and has been linked to menstrual irregularities, subfertility, and changes in sex steroid concentrations. Chronic and heavy alcohol use may further exacerbate these disturbances through direct gonadal toxicity, oxidative stress, and modulation of neuroendocrine pathways involved in stress and energy balance.24,25 In parallel, alcohol intake influences systemic metabolism, including glucose-lipid homeostasis and body composition. Ethanol provides energy but cannot be stored, and its preferential hepatic metabolism promotes triglyceride synthesis, steatosis, and dyslipidemia, while also affecting insulin sensitivity and gluconeogenesis. These metabolic effects contribute to central adiposity, insulin resistance, and an adverse cardiometabolic profile, even at moderate consumption in susceptible individuals. Because the HPO axis is highly sensitive to changes in energy availability, adiposity, and insulin signaling, alcohol‑related metabolic perturbations may indirectly affect reproductive endocrine function, creating a bidirectional link between alcohol consumption, metabolic health, and ovarian function.25–27

Emerging evidence suggests that certain types of tea may have beneficial adjunctive effects in women with PCOS, particularly through metabolic and hormonal pathways. Green tea and green tea extracts, which are rich in catechins and other antioxidants, have been reported in small clinical trials and systematic reviews to promote modest weight loss, improve fasting glucose and insulin levels, and reduce markers of insulin resistance in women with PCOS, changes that could secondarily improve ovulatory function and hyperandrogenism. Some studies also indicate potential reductions in free testosterone and improvements in reproductive hormone profiles and ovulatory parameters, although findings are not entirely consistent and sample sizes are often limited.28,29 Despite these findings, observational studies can be susceptible to confounders and biases, thus restricting the capacity to conclusively ascertain the direct impact of sugar-sweetened beverages on PCOS. Besides, the causal effects of PCOS on sugar-sweetened beverage intake have been largely unknown, which hinders the management of sugar-sweetened beverage intake.

Mendelian randomization (MR) offers a robust approach for assessing causal relationships in epidemiology by using genetic variants as instrumental variables (IVs), thereby reducing confounding and reverse causation.30 This method relies on the random allocation of alleles during meiosis, analogous to the randomization process in traditional randomized controlled trials (RCTs).

In this study, a two-sample MR framework was employed to explore the potential causal link between sugar-sweetened beverage consumption and the PCOS risk. By elucidating this potential causal pathway, the study could contribute to the understanding of PCOS etiology and offer insights into potential preventive strategies targeting modifiable dietary behaviors to prevent or manage PCOS.

Materials and Methods

Study Design

A two-sample MR analysis was conducted to examine the potential causal relationship between PCOS and dietary factors. The study utilized publicly available summary-level data from previously published genome-wide association studies (GWAS), which involved de-identified participants. The ethics committee of Obstetrics & Gynecology Hospital of Fudan University confirmed that ethical approval was not required for this study because it was based solely on publicly available, de-identified summary data from previously published genome-wide association studies (GWAS). According to the Measures for Ethical Review of Life Science and Medical Research Involving Human Subjects (Article 32, February 18, 2023, China), such research is exempt from ethics committee review.

Genetic variants associated with PCOS were initially selected as IVs to assess their effect on sugar-sweetened beverage intake and related dietary traits. In a reverse analysis, variants linked to sugar-sweetened beverage intake were also used as IVs to explore their potential influence on PCOS risk. Instrument selection followed the key assumptions of MR:31 (1) the single nucleotide polymorphisms (SNPs) are strongly associated with the exposure, (2) they are independent of confounding variables, and (3) they influence the outcome solely through the exposure of interest. The study design is illustrated in Figure 1.

Figure 1.

Flowchart of bidirectional Mendelian randomization analysis of sugar-sweetened beverage intake and PCOS. It begins with 'Confounding factors' influencing both 'Exposure' and 'Outcome'. 'Exposure' includes sugar-sweetened coffee and tea intake. 'Outcome' is polycystic ovary syndrome. Arrows indicate the direction of analysis. 'Selection of IVs' for both exposure and outcome includes criteria: P value less than 5 by 10 superscript negative 6 or 5 by 10 superscript negative 8, minor allele frequency greater than 0.01, linkage disequilibrium R squared less than 0.001, not palindromic SNPs and F-statistic values greater than 10. The flowchart shows the process of selecting instrumental variables for the analysis.

Flowchart of the study design. A bidirectional Mendelian randomization analysis of sugar-sweetened beverage intake and polycystic ovary syndrome.

Data Sources

PCOS summary statistics were obtained from a large-scale population-based case-control GWAS within the FinnGen cohort,32 which combines genomic data with nationwide electronic health records in Finland.33 The dataset (GWAS ID FINNGEN_R12_E4_PCOS) included 2214 diagnosed cases of PCOS (ICD-10 code E28.2) and 267,780 controls of European ancestry. FinnGen participants were recruited from Finnish biobanks via samples collected over decades, spanning legacy collections from the late 1980s through prospective sampling up to spring 2023. Genetic data on sugar-sweetened beverage intake, including sugar-sweetened coffee and tea, and dietary factors were sourced from the UK Biobank by self-reported questionnaire. The UK Biobank is a large-scale prospective cohort study that enhances comprehension of the genetic and environmental factors influencing various health conditions, encompassing over 500,000 participants aged 40 to 69 years enrolled between 2006 and 2010.34 The datasets are presented in Table S1. To minimize population stratification bias, all SNPs and summary statistics were obtained exclusively from studies involving individuals of European descent.

Selection of IVs

IVs were selected under strict quality control to satisfy the core assumptions of MR. SNPs significantly associated with sugar-sweetened beverage intake and PCOS were initially screened using a genome-wide significance threshold of P < 5×108. For dietary traits with limited associated SNPs, such as sugar added to coffee or tea, bran cereal, and oat cereal, the threshold was relaxed to P < 5×106 to retain sufficient instruments. Variants with a minor allele frequency (MAF) ≤ 0.01 were excluded. To control for linkage disequilibrium (LD), SNPs within 10,000 kb and R2 ≥ 0.001 were removed.35 When outcome data lacked specific SNPs, proxy variants in strong LD (R2 > 0.8) were substituted to maintain instrument strength. Palindromic SNPs were discarded to avoid strand ambiguity, and harmonization aligned effect alleles with the reference human genome (build 37), excluding duplicates and ambiguous variants.33 Instrument strength was evaluated using the F-statistic, with values above 10 indicating sufficient strength and low susceptibility to weak instrument bias.36

MR Analysis

The inverse variance weighted (IVW) method served as the primary approach to estimate causal effects between dietary exposures and PCOS. IVW calculates a weighted average of SNP-specific estimates, using the inverse of their variance as weights.37 To validate findings and account for pleiotropy, additional analyses were conducted using MR-Egger regression, weighted median, and weighted mode methods. MR-Egger accommodates directional pleiotropy through an intercept term.37 The weighted median approach yields consistent estimates if at least half the instruments are valid.38 The weighted mode method identifies the most frequent causal estimate across all IVs, incorporating a weight distribution based on SNP precision.39 All MR analyses were performed using the “TwoSampleMR” R package (version 0.4.26), and results were visualized through scatter plots and diagnostic graphics.

Sensitivity Analysis

Heterogeneity across SNP estimates was tested using Cochran’s Q statistic, with significance defined as P < 0.05. To assess robustness, leave-one-out analysis iteratively removed individual SNPs to evaluate their influence on the overall causal estimate. Funnel plots were used to visualize asymmetry, which may indicate heterogeneity or outliers. MR-Egger regression further tested for horizontal pleiotropy, where a non-significant intercept suggests minimal directional bias.40 The MR pleiotropy residual sum and outlier (MR-PRESSO) method was applied to detect and remove outlier variants,41 and causal estimates were recalculated after exclusion to correct for pleiotropic distortion.

Results

Selection of IVs

The detailed SNP information is listed in Table S2. The IV numbers for each exposure and the F-values are listed in Table S3. All F-values were >10, indicating the absence of weak instrumental bias. The unmatching and palindromic SNPs are shown in Table S3. Those SNPs could not be used in the MR analysis and were replaced, when possible, by the SNPs indicated in Table S3.

Causal Associations of Dietary Factors on PCOS

The IVW analysis identified potential causal associations between PCOS and two dietary exposures: alcohol intake frequency (OR = 1.39, 95% CI: 1.03–1.88, P = 0.03) and sugar added to tea (OR = 0.43, 95% CI: 0.21–0.89, P = 0.022) (Table 1). However, these associations were not corroborated by the MR-Egger regression, weighted median, and weighted mode methods, as none yielded statistically significant results (all P > 0.05; Table S4), indicating that the results should be interpreted with caution. Scatter plots and forest plots for these associations are presented in Figures 2A, B and 3A, B. The scatter plots represent the estimated causal effect of the exposure on the outcome. In the MR scatter plot, each point represents an SNP, with its association with exposure on the x‑axis and with outcome (PCOS) on the y‑axis; the slope of the fitted IVW line corresponds to the overall causal estimate of the exposure on PCOS. The forest plot indicates the association of each individual SNP from the exposure with PCOS.

Table 1.

Causal Relationships Between Dietary Factors and PCOS in the MR Analysis (Due to the Extensive Results, Only the IVW Results are Displayed Here. The Complete Results Can Be Found in Table S3)

Exposure Outcome n SNP Method OR (95% CI) P
Alcoholic drinks per week Polycystic ovarian syndrome 34 Inverse variance weighted 1.24 (0.48–3.17) 0.657
Bread intake Polycystic ovarian syndrome 30 Inverse variance weighted 1.18 (0.33–4.21) 0.799
Bread intake Polycystic ovarian syndrome 28 Inverse variance weighted 0.59 (0.21–1.64) 0.313
Lamb or mutton intake Polycystic ovarian syndrome 31 Inverse variance weighted 1.42 (0.40–5.02) 0.59
Hot drink temperature Polycystic ovarian syndrome 68 Inverse variance weighted 0.85 (0.33–2.21) 0.744
Cheese intake Polycystic ovarian syndrome 64 Inverse variance weighted 0.55 (0.29–1.04) 0.066
Water intake Polycystic ovarian syndrome 39 Inverse variance weighted 1.57 (0.67–3.68) 0.304
Cereal intake Polycystic ovarian syndrome 39 Inverse variance weighted 1.08 (0.43–2.73) 0.873
Dark chocolate intake Polycystic ovarian syndrome 14 Inverse variance weighted 1.45 (0.32–6.61) 0.635
Dried fruit intake Polycystic ovarian syndrome 40 Inverse variance weighted 1.16 (0.46–2.90) 0.752
Alcohol usually taken with meals Polycystic ovarian syndrome 33 Inverse variance weighted 0.88 (0.24–3.20) 0.844
Average weekly spirits intake Polycystic ovarian syndrome 4 Inverse variance weighted 0.73 (0.05–9.85) 0.814
Non-oily fish intake Polycystic ovarian syndrome 11 Inverse variance weighted 1.81 (0.19–17.29) 0.606
Salad or raw vegetable intake Polycystic ovarian syndrome 19 Inverse variance weighted 1.90 (0.31–11.88) 0.49
Oily fish intake Polycystic ovarian syndrome 61 Inverse variance weighted 1.30 (0.67–2.54) 0.443
Intake of sugar added to coffee Polycystic ovarian syndrome 14 Inverse variance weighted 0.93 (0.41–2.10) 0.854
Beef intake Polycystic ovarian syndrome 15 Inverse variance weighted 0.39 (0.09–1.63) 0.196
Fresh fruit intake Polycystic ovarian syndrome 53 Inverse variance weighted 3.20 (0.92–11.16) 0.068
Fresh fruit intake (after outlier removal) Polycystic ovarian syndrome 51 Inverse variance weighted 2.91 (0.94–8.98) 0.063
Average weekly beer plus cider intake Polycystic ovarian syndrome 19 Inverse variance weighted 0.82 (0.18–3.83) 0.803
Coffee intake Polycystic ovarian syndrome 39 Inverse variance weighted 1.64 (0.70–3.81) 0.254
Coffee intake (after outlier removal) Polycystic ovarian syndrome 39 Inverse variance weighted 1.91 (0.86–4.25) 0.112
Average weekly red wine intake Polycystic ovarian syndrome 18 Inverse variance weighted 0.90 (0.25–3.22) 0.865
Pork intake Polycystic ovarian syndrome 13 Inverse variance weighted 1.26 (0.14–11.76) 0.838
Average weekly champagne plus white wine intake Polycystic ovarian syndrome 4 Inverse variance weighted 0.60 (0.04–7.98) 0.698
Alcohol intake frequency Polycystic ovarian syndrome 96 Inverse variance weighted 1.39 (1.03–1.88) 0.03
Tea intake Polycystic ovarian syndrome 39 Inverse variance weighted 1.00 (0.48–2.07) 0.991
Tea intake (after outlier removal) Polycystic ovarian syndrome 38 Inverse variance weighted 0.86 (0.44–1.66) 0.649
Processed meat intake Polycystic ovarian syndrome 23 Inverse variance weighted 0.51 (0.15–1.72) 0.275
Poultry intake Polycystic ovarian syndrome 7 Inverse variance weighted 1.12 (0.10–12.40) 0.928
Cooked vegetable intake Polycystic ovarian syndrome 17 Inverse variance weighted 1.64 (0.22–12.13) 0.629
Salt added to food Polycystic ovarian syndrome 101 Inverse variance weighted 0.83 (0.50–1.37) 0.465
Intake of sugar added to tea Polycystic ovarian syndrome 18 Inverse variance weighted 0.43 (0.21–0.89) 0.022
Bran cereal (e.g., All Bran, Branflakes) Polycystic ovarian syndrome 12 Inverse variance weighted 0.06 (0.00–2.68) 0.149
Biscuit cereal (e.g., Weetabix) Polycystic ovarian syndrome 2 Inverse variance weighted 0.98 (0.00–2842.31) 0.996
Oat cereal (e.g., Ready Brek, porridge) Polycystic ovarian syndrome 20 Inverse variance weighted 1.89 (0.16–22.30) 0.612
Muesli Polycystic ovarian syndrome 10 Inverse variance weighted 2.34 (0.05–106.04) 0.662
Other (e.g., Cornflakes, Frosties) Polycystic ovarian syndrome 10 Inverse variance weighted 0.42 (0.01–19.78) 0.66

Figure 2.

A four-graph figure showing MR scatter, forest, leave-one-out forest and funnel plots for PCOS. The image A showing a scatter plot labeled “MR Test” with legend entries “Inverse variance weighted”, “MR Egger”, “Weighted median” and “Weighted mode”. The x-axis label is “SNP effect on Alcohol intake frequency” (unit not shown), with visible ticks at 0.1 and 0.2. The y-axis label is “SNP effect on Polycystic ovarian syndrome” (unit not shown), with visible ticks at negative 0.4, negative 0.2, 0.0 and 0.2. Points with horizontal and vertical error bars cluster near x close to 0.0 and y near 0.0. One point lies near x about 0.25 and y about negative 0.2. Four fitted lines are present: three upward sloping and one downward sloping. The image B showing a forest plot with many rows labeled by single nucleotide polymorphism identifiers (unclear). The x-axis label is “MR effect size for ‘Alcohol intake frequency’ on ‘Polycystic ovarian syndrome’” (unit not shown). The x-axis shows ticks at negative 5, 0 and 5, with a vertical reference line at 0. Each row shows a dot with a horizontal confidence interval; dots form a near-vertical column around 0. A bottom summary label reads “All - Inverse variance weighted - MR Egger” (remaining text unclear). The image C showing a leave-one-out forest plot with many rows labeled by single nucleotide polymorphism identifiers (unclear) and a bottom row labeled “All”. The x-axis label is “MR leave-one-out sensitivity analysis for ‘Alcohol intake frequency’ on ‘Polycystic ovarian syndrome’” (unit not shown). The x-axis shows ticks at 0.0, 0.2, 0.4 and 0.6. A vertical reference line is near 0.2. Each row shows a dot with a horizontal confidence interval; dots align near the reference line. The image D showing a funnel plot with legend “MR Method” and entries “Inverse variance weighted” and “MR Egger”. The x-axis label is “Beta subscript IV” (unit not shown), with visible ticks at negative 2, 0, 2 and 4. The y-axis label is “1 slash SEv” (unit not shown), with visible ticks at 0.4, 0.8, 1.2 and 1.6. Points span x from about negative 3 to about 5 and y from about 0.4 to about 1.6, with two vertical lines near x around 0. Across A to D, all plots refer to “Alcohol intake frequency” and “Polycystic ovarian syndrome”, with A showing per-variant associations and fitted method lines, B showing per-variant effect estimates with confidence intervals, C showing leave-one-out estimates including “All” and D showing the distribution of estimates versus precision.

The causal relationships between alcohol intake frequency and PCOS using Mendelian randomization. (A) Scatter plot. (B) Forest plot. (C) Leave-one-out forest plot. (D) Funnel plot.

Figure 3.

Four graphs showing Mendelian randomization results for sugar added to tea and polycystic ovarian syndrome. The image A showing a scatter plot with legend text: MR Test; Inverse variance weighted; MR Egger; Weighted median; Weighted mode. X-axis label: SNP effect on Intake of sugar added to tea (unit not shown), ticks 0.02, 0.04, 0.06, 0.08. Y-axis label: SNP effect on Polycystic ovarian syndrome (unit not shown), ticks 0.1, 0.0, negative 0.1, negative 0.2. Multiple points with horizontal and vertical error bars. All four fitted method lines slope downward from near y equals 0 at x around 0.02 toward y around negative 0.1 by x around 0.08. The image B showing a forest plot of single nucleotide polymorphism estimates and two summary estimates. X-axis label: MR effect size for Intake of sugar added to tea on Polycystic ovarian syndrome (unit not shown), ticks negative 4, 0, 4, with a vertical dotted reference at 0. Y-axis labels: rs237362, rs148796113, rs549845, rs58566315, rs9851099, rs12184890, rs4750827, rs506917, rs6107831, rs111744095, rs72867690, rs6737082, rs56094641, rs11643519, rs2527164, rs1727742, rs7910578, rs72682980. Each row shows a dot with a horizontal confidence interval; dots appear on both sides of 0. Summary rows: All - MR Egger and All - Inverse variance weighted, both plotted left of 0. The image C showing a leave-one-out forest plot. X-axis label: MR leave-one-out sensitivity analysis for Intake of sugar added to tea on Polycystic ovarian syndrome (unit not shown), ticks negative 1.5, negative 1.0, negative 0.5, 0.0, with a vertical dotted reference at 0. Y-axis labels: rs7910578, rs72682980, rs56094641, rs1727742, rs2527164, rs6737082, rs11643519, rs72867690, rs6107831, rs111744095, rs506917, rs4750827, rs9851099, rs12184890, rs549845, rs148796113, rs58566315, rs237362 and All. Most leave-one-out dots cluster between about negative 1.0 and negative 0.5; the All summary dot is near negative 0.8 with a horizontal interval. The image D showing a funnel plot with legend text: MR Method; Inverse variance weighted; MR Egger. X-axis label: beta subscript i v (unit not shown), ticks negative 3, negative 2, negative 1, 0, 1, 2. Y-axis label: 1 slash SEiv (unit not shown), ticks 0.4, 0.5, 0.6, 0.7, 0.8. Points are scattered, with higher 1 slash SEiv values around 0.7 to 0.8 and lower values around 0.4 to 0.5. Two vertical reference lines are drawn near negative 2 and negative 1. The four graphs collectively present Mendelian randomization scatter, per single nucleotide polymorphism forest estimates, leave-one-out sensitivity forest estimates and a funnel plot for the same exposure and outcome.

The causal relationships between intake of sugar in tea and PCOS using Mendelian randomization. (A) Scatter plot. (B) Forest plot. (C) Leave-one-out forest plot. (D) Funnel plot.

Leave-one-out analyses are performed by sequentially excluding each SNP in turn and examining whether the exclusion of a single SNP influences the association. Leave-one-out analyses demonstrated that no single instrumental variable disproportionately influenced the results (Figures 2C and 3C). Approximately symmetrical funnel plots suggest the absence of directional pleiotropy, heterogeneity, and outliers. Here, the funnel plots suggested a lack of heterogeneity and outliers (Figures 2D and 3D).

Heterogeneity reflects inconsistency between SNP-specific causal estimates beyond that expected by chance, which can indicate pleiotropy or violation of the instrumental variable assumptions. Cochran’s Q test revealed significant heterogeneity in several exposures, including alcohol consumption, bread, cereal, cheese, coffee, vegetables, fruits, processed meat, and tea (P-values < 0.05; Table 2). Horizontal pleiotropy occurs when genetic instruments affect the outcome via pathways independent of the exposure, potentially biasing MR estimates if not appropriately accounted for. MR-Egger intercepts showed no evidence of horizontal pleiotropy across the analyses (all P > 0.05; Table 2). MR-PRESSO identified outlier SNPs for coffee, bread, fresh fruit, and tea intake (Table 3), but exclusion of these variants and re-estimation via IVW yielded consistent findings (Table 1, “after exclusion” rows).

Table 2.

Heterogeneity and Horizontal Pleiotropy Between Sugar-Sweetened Beverage Intake and PCOS

Exposure Outcome Heterogeneity Pleiotropy
Q Statistic
(IVW)
P value MR-Egger
Intercept
P value
Alcohol intake frequency Polycystic ovarian syndrome 88.43105 0.669792 0.017084 0.136782
Alcohol usually taken with meals 21.87155 0.910783 0.015386 0.702427
Alcoholic drinks per week 53.2659 0.014194 0.001536 0.936442
Average weekly beer plus cider intake 26.31965 0.092671 0.03672 0.402048
Average weekly champagne plus white wine intake 1.172461 0.759617 −0.02505 0.961088
Average weekly red wine intake 21.84438 0.190778 −0.05992 0.192583
Average weekly spirits intake 3.710296 0.294494 0.145762 0.231352
Beef intake 8.302671 0.872969 −0.01275 0.817122
Biscuit cereal (e.g., Weetabix) 0.014875 0.902929
Bran cereal (e.g., All Bran, Branflakes) 4.717236 0.944084 0.017494 0.570092
Bread intake 63.54115 0.00022 0.005414 0.904656
Bread intake (after outlier removal) 35.22298 0.133307 0.027233 0.439566
Cereal intake 53.44004 0.049469 0.00311 0.916153
Cheese intake 88.13894 0.019994 −0.02072 0.372432
Coffee intake 55.26841 0.034717 −0.00791 0.582521
Coffee intake (after outlier removal) 47.06881 0.12415 −0.00433 0.749729
Cooked vegetable intake 27.77658 0.033618 0.003671 0.97565
Dark chocolate intake 13.21669 0.431217 0.059464 0.060159
Dried fruit intake 44.74017 0.243453 0.001475 0.95533
Fresh fruit intake 81.08681 0.006051 −0.00055 0.978574
Fresh fruit intake (after outlier removal) 60.80756 0.14073 0.010844 0.550029
Hot drink temperature 70.28883 0.368061 0.013676 0.475642
Intake of sugar added to coffee 13.73561 0.392724 0.007718 0.823558
Intake of sugar added to tea 15.12005 0.586835 0.025537 0.396142
Lambormutton intake 33.69057 0.293372 0.015995 0.599827
Muesli 13.56421 0.138694 0.013843 0.884709
Non-oily fish intake 17.65105 0.061143 0.03909 0.585558
Oat cereal (e.g., Ready Brek, porridge) 16.37192 0.632337 0.002882 0.912081
Oily fish intake 70.60485 0.164445 0.003324 0.875391
Other (e.g., Cornflakes, Frosties) 13.6318 0.136039 −0.08156 0.401548
Pork intake 18.16402 0.1108 0.030339 0.69599
Poultry intake 6.773096 0.342342 −0.63785 0.149784
Processed meat intake 35.4738 0.034547 0.055988 0.242396
Salad or raw vegetable intake 21.7132 0.244967 0.023123 0.637409
Salt added to food 110.0563 0.231066 0.008001 0.526944
Tea intake 59.14253 0.015579 −0.01018 0.528133
Tea intake (after outlier removal) 45.74621 0.15332 −0.01293 0.36821
Water intake 47.28716 0.143609 0.015696 0.399457

Notes: Cochran’s Q statistic is used for detecting heterogeneity about the IVW estimate.

Table 3.

Detection and Correction of Horizontal Pleiotropy Using MR-PRESSO Method

Exposure Outcome Raw Outlier Corrected Global P Number of
Outliers
Distortion P
OR (CI%) P OR (CI%) P
Hot drink temperature Polycystic ovarian
syndrome
0.85 (0.33–2.21) 0.75 NA (NA - NA) NA 0.365
Oily fish intake 1.30 (0.67–2.54) 0.45 NA (NA - NA) NA 0.182
Salt added to food 0.83 (0.50–1.37) 0.47 1.91 (0.86–4.25) 0.12 0.206
Coffee intake 1.64 (0.70–3.81) 0.26 NA (NA - NA) NA 0.043 rs780093 0.765
Coffee intake (after outlier removal) 1.91 (0.86–4.25) 0.12 NA (NA - NA) NA 0.131
Alcohol intake frequency 1.39 (1.04–1.86) 0.03 NA (NA - NA) NA 0.649
Cheese intake 0.55 (0.29–1.04) 0.07 NA (NA - NA) NA 0.026 NA
Water intake 1.57 (0.67–3.68) 0.31 0.59 (0.21–1.64) 0.32 0.117
Bread intake 1.18 (0.33–4.21) 0.8 NA (NA - NA) NA <0.001 rs4665972,rs6580721 0.324
Bread intake (after outlier removal) 0.59 (0.21–1.64) 0.32 NA (NA - NA) NA 0.149
Beef intake 0.39 (0.13–1.17) 0.12 NA (NA - NA) NA 0.862
Dried fruit intake 1.16 (0.46–2.90) 0.75 NA (NA - NA) NA 0.228
Cereal intake 1.08 (0.43–2.73) 0.87 2.91 (0.94–8.98) 0.07 0.045 NA
Fresh fruit intake 3.20 (0.92–11.16) 0.07 NA (NA - NA) NA 0.007 rs28479795,rs586346 0.858
Fresh fruit intake (after outlier removal) 2.91 (0.94–8.98) 0.07 NA (NA - NA) NA 0.133
Alcoholic drinks per week 1.24 (0.48–3.17) 0.66 NA (NA - NA) NA 0.011 NA
Cooked vegetable intake 1.64 (0.22–12.13) 0.64 NA (NA - NA) NA 0.036 NA
Bran cereal (e.g., All Bran, Branflakes) 0.06 (0.01–0.74) 0.05 NA (NA - NA) NA 0.939
Dark chocolate intake 1.45 (0.32–6.61) 0.64 NA (NA - NA) NA 0.451
Processed meat intake 0.51 (0.15–1.72) 0.29 NA (NA - NA) NA 0.027 NA
Poultry intake 1.12 (0.10–12.40) 0.93 NA (NA - NA) NA 0.377
Salad or raw vegetable intake 1.90 (0.31–11.88) 0.5 0.86 (0.44–1.66) 0.65 0.249
Tea intake 1.00 (0.48–2.07) 0.99 NA (NA - NA) NA 0.019 rs72797284 0.847
Tea intake (after outlier removal) 0.86 (0.44–1.66) 0.65 NA (NA - NA) NA 0.148
Alcohol usually taken with meals 0.88 (0.30–2.56) 0.81 NA (NA - NA) NA 0.889
Average weekly red wine intake 0.90 (0.25–3.22) 0.87 NA (NA - NA) NA 0.181
Average weekly beer plus cider intake 0.82 (0.18–3.83) 0.81 NA (NA - NA) NA 0.1
Pork intake 1.26 (0.14–11.76) 0.84 NA (NA - NA) NA 0.118
Muesli 2.34 (0.05–106.04) 0.67 NA (NA - NA) NA 0.154
Oat cereal (e.g., Ready Brek, porridge) 1.89 (0.19–18.68) 0.59 NA (NA - NA) NA 0.636
Lambormutton intake 1.42 (0.40–5.02) 0.59 NA (NA - NA) NA 0.307
Intake of sugar added to tea 0.43 (0.22–0.85) 0.03 NA (NA - NA) NA 0.579
Other (e.g., Cornflakes, Frosties) 0.42 (0.01–19.78) 0.67 NA (NA - NA) NA 0.168
Non-oily fish intake 1.81 (0.19–17.29) 0.62 NA (NA - NA) NA 0.053
Intake of sugar added to coffee 0.93 (0.41–2.10) 0.86 NA (NA - NA) NA 0.402
Average weekly champagne plus white wine intake 0.60 (0.12–3.02) 0.58 NA (NA - NA) NA 0.774
Average weekly spirits intake 0.73 (0.05–9.85) 0.83 NA (NA - NA) NA 0.339

Discussion

This two-sample MR study examined the potential causal links between dietary exposures, including sugar-sweetened beverage intake, and PCOS. The findings indicated that genetically predicted alcohol intake frequency was positively associated with PCOS risk, whereas the intake of sugar added to tea showed a potential protective effect. These results warrant further investigation to confirm their validity and explore the underlying mechanism.

The association between alcohol intake and PCOS observed in the IVW analysis aligned with previous epidemiological evidence. Alcohol consumption may disrupt endocrine function in women by altering estrogen levels, impairing menstrual regularity, and exacerbating insulin resistance.42–44 In addition, alcohol intake has been linked to metabolic disturbances—including obesity, insulin resistance, and hypertension45,46—which commonly co-occur in individuals with PCOS.47 Alcohol consumption can disrupt lipid metabolism, leading to increased triglyceride levels, reduced HDL cholesterol, and potentially contributing to steatosis.48,49 Alcohol can interfere with glucose metabolism, leading to insulin resistance and potentially contributing to type 2 diabetes.50,51 Alcohol is calorie-dense, and excessive consumption can contribute to weight gain and obesity.48 In addition, alcohol can damage the intestinal barrier, leading to increased gut permeability and the release of toxins into the bloodstream, which can contribute to liver inflammation and metabolic dysfunction.52 Clinically, patients with PCOS or at risk of PCOS should be recommended to limit their alcohol intake.

This study identified a potential protective causal association between the intake of sugar added to tea and the PCOS risk, a finding that contrasts with prior observational research. For instance, a positive relationship was noted between sugar-sweetened beverage consumption and PCOS prevalence among reproductive-age women.13 Conversely, a hospital-based case-control study suggested an inverse association between coffee intake and PCOS risk.53 Another study found no significant relationship between the intake of caffeinated or sugary beverages and antral follicle count, an indicator of ovarian reserve.54 Possible explanations include that unmeasured confounding factors not accounted for in our analysis could influence the observed associations. The non-linear and multifactorial nature of PCOS, influenced by genetic, environmental, and lifestyle factors, may also contribute to the observed findings.55

There is also a possibility that that particular variable has a confounder effect because sugar intake in teas involves tea consumption. Although the a priori hypothesis considered added sugar as a potential risk factor, an apparently protective association was observed for sugar in tea. This finding is difficult to reconcile with the broader literature, which consistently links high intakes of added sugars and sugar‑sweetened beverages with insulin resistance, adverse metabolic profiles, and features that overlap with PCOS pathophysiology.13,56 Experimental and epidemiologic data indicate that diets rich in added sugars promote hyperinsulinemia, visceral adiposity, and impaired glucose tolerance, all of which are established contributors to reproductive and metabolic disturbances in women of reproductive age. Therefore, a genuine protective effect of sugar itself on PCOS risk appears biologically implausible. A more plausible explanation is that sugar in tea behaves as a behavioral proxy for tea consumption rather than reflecting a direct benefit of sugar. Indeed, a meta-analysis showed that tea consumption by women with PCOS improved insulin resistance parameters and body weight.57 Green tea extracts also have beneficial effects in women with PCOS,29 and green tea promotes weight loss in women with PCOS.58 On the other hand, Tea intake, before or after outlier removal, was not causally associated with PCOS in the present study. Those results warrant further investigation. The lack of significance for “tea intake” itself, contrasted with the significant protective effect of “sugar in tea,” might be attributed to differences in the statistical power of the genetic instruments or the possibility that “sugar in tea” acts as a more specific behavioral marker for long-term, high-volume tea consumption patterns in this particular cohort. It is therefore conceivable that individuals who typically add sugar to tea differ from non‑users in overall tea intake patterns or correlated lifestyle characteristics, and that any apparent protective signal is driven by tea itself or residual confounding rather than the sugar added to it. Consequently, this result should be interpreted cautiously, and we do not infer a causal protective role of sugar from this association.

Except for the two dietary factors described above, no causal associations have been identified despite the fact that observational studies associated the Western diet with PCOS.22,23 Diseases are often the result of the interactions of several genetic and environmental factors.59,60 These inconsistencies may reflect the influence of environmental modifiers or residual confounding that MR analyses cannot fully account for. Negative or counterintuitive MR findings do not necessarily exclude a causal relationship; they may result from weak genetic instruments or insufficient variance explained by the selected SNPs. Such limitations are well recognized in MR studies, especially when genetic proxies exert minimal effects on the exposure of interest. To address these complexities, future research should consider multivariable MR approaches that account for potential confounders and explore gene–environment interactions.

The present analysis offered several strengths. First, it is the first MR study to investigate the causal effects of specific dietary factors on PCOS, offering novel insights into the potential role of modifiable lifestyle factors in disease prevention.61 Second, the use of multiple complementary MR methods further strengthens the reliability of the findings. The results from the sensitivity analyses further corroborated the validity of the associations or their lack thereof. However, the analysis still has limitations. First, generalizability remains limited, as the analysis was based exclusively on individuals of European ancestry. Caution is therefore warranted when extending these results to other populations, such as those of Asian descent. Second, the FinnGen database contained only a small number of participants with PCOS. Third, while MR analysis can help mitigate confounding by measured and unmeasured factors, residual confounding may still exist due to unaccounted environmental or genetic factors, potentially influencing the observed causal estimates.

Conclusion

This study supports, through genetic evidence, that frequent alcohol consumption is a potential causal risk factor for PCOS, and that added sugar to tea shows an unexpected negative correlation (but it may be influenced by the benefits of tea itself). Analyses have not found a direct genetic causal association between 36 other dietary factors, including sugary coffee and most soft drinks, and PCOS. This underscores the importance of limiting alcohol intake in the management of PCOS. External validation of the results remains necessary.

Funding Statement

The study was supported by the Natural Science Foundation of China (81871132). The funders had no role in study design, data collection, and analysis, the decision to publish, or preparation of the manuscript.

Data Sharing Statement

All data generated or analyzed during this study are included in this article and supplementary information files.

Ethics Approval and Informed Consent

The ethics committee of Obstetrics & Gynecology Hospital of Fudan University confirmed that ethical approval was not required for this study because it was based solely on publicly available, de-identified summary data from previously published genome-wide association studies (GWAS). According to the Measures for Ethical Review of Life Science and Medical Research Involving Human Subjects (Article 32, February 18, 2023, China), such research is exempt from ethics committee review.

Author Contributions

All authors made a significant contribution to the work reported, whether that is in the conception, study design, execution, acquisition of data, analysis and interpretation, or in all these areas; took part in drafting, revising or critically reviewing the article; gave final approval of the version to be published; have agreed on the journal to which the article has been submitted; and agree to be accountable for all aspects of the work.

Disclosure

The authors declare that they have no competing interests in this work.

References

  • 1.Huddleston HG, Dokras A. Diagnosis and treatment of polycystic ovary syndrome. JAMA. 2022;327(3):274–14. doi: 10.1001/jama.2021.23769 [DOI] [PubMed] [Google Scholar]
  • 2.Teede HJ, Tay CT, Laven JJE, et al. Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Eur J Endocrinol. 2023;189(2):G43–G64. doi: 10.1093/ejendo/lvad096 [DOI] [PubMed] [Google Scholar]
  • 3.Zheng X, Wang CC. Is polycystic ovary syndrome undervalued in China? Lancet Regional Health. 2022;25:100513. doi: 10.1016/j.lanwpc.2022.100513 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Guo F, Gong Z, Fernando T, Zhang L, Zhu X, Shi Y. The lipid profiles in different characteristics of women with PCOS and the interaction between dyslipidemia and metabolic disorder states: a retrospective study in Chinese population. Front Endocrinol. 2022;13:892125. doi: 10.3389/fendo.2022.892125 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Zhu T, Cui J, Goodarzi MO. Polycystic ovary syndrome and risk of type 2 diabetes, coronary heart disease, and stroke. Diabetes. 2021;70(2):627–637. doi: 10.2337/db20-0800 [DOI] [PubMed] [Google Scholar]
  • 6.Pinto J, Cera N, Pignatelli D. Psychological symptoms and brain activity alterations in women with PCOS and their relation to the reduced quality of life: a narrative review. J Endocrinol Invest. 2024;47(7):1–22. doi: 10.1007/s40618-024-02329-y [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Azziz R, Carmina E, Chen Z, et al. Polycystic ovary syndrome. Nat Rev Dis Primers. 2016;2:16057. doi: 10.1038/nrdp.2016.57 [DOI] [PubMed] [Google Scholar]
  • 8.Eiras MC, Pinheiro DP, Romcy KAM, Ferriani RA, Reis RMD, Furtado CLM. Polycystic ovary syndrome: the epigenetics behind the disease. Reprod Sci. 2022;29(3):680–694. doi: 10.1007/s43032-021-00516-3 [DOI] [PubMed] [Google Scholar]
  • 9.Valgeirsdottir H, Vanky E, Sundström-Poromaa I, et al. Prenatal exposures and birth indices, and subsequent risk of polycystic ovary syndrome: a national registry-based cohort study. Bjog. 2019;126(2):244–251. doi: 10.1111/1471-0528.15236 [DOI] [PubMed] [Google Scholar]
  • 10.Bruni V, Capozzi A, Lello S. The role of genetics, epigenetics and lifestyle in polycystic ovary syndrome development: the state of the art. Reprod Sci. 2022;29(3):668–679. doi: 10.1007/s43032-021-00515-4 [DOI] [PubMed] [Google Scholar]
  • 11.Roberts JS, Perets RA, Sarfert KS, et al. High-fat high-sugar diet induces polycystic ovary syndrome in a rodent model. Biol Reprod. 2017;96(3):551–562. doi: 10.1095/biolreprod.116.142786 [DOI] [PubMed] [Google Scholar]
  • 12.Volk KM, Pogrebna VV, Roberts JA, Zachry JE, Blythe SN, Toporikova N. High-Fat, high-sugar diet disrupts the preovulatory hormone surge and induces cystic ovaries in cycling female rats. J Endocrine Soc. 2017;1(12):1488–1505. doi: 10.1210/js.2017-00305 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.De Melo GB, Soares JF, Costa TCL, et al. Early exposure to high-sucrose diet leads to deteriorated ovarian health. Front Endocrinol. 2021;12:656831. doi: 10.3389/fendo.2021.656831 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Szczuko M, Kikut J, Szczuko U, et al. Nutrition strategy and life style in polycystic ovary syndrome—narrative review. Nutrients. 2021;13(7):2452. doi: 10.3390/nu13072452 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Malik VS, Popkin BM, Bray GA, Després JP, Hu FB. Sugar-sweetened beverages, obesity, type 2 diabetes mellitus, and cardiovascular disease risk. Circulation. 2010;121(11):1356–1364. doi: 10.1161/CIRCULATIONAHA.109.876185 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Lara-Castor L, Micha R, Cudhea F, et al. Sugar-sweetened beverage intakes among adults between 1990 and 2018 in 185 countries. Nat Commun. 2023;14(1):5957. doi: 10.1038/s41467-023-41269-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Gan Q, Xu P, Yang T, et al. Sugar-sweetened beverage consumption status and its association with childhood obesity among Chinese children aged 6–17 years. Nutrients. 2021;13(7):2211. doi: 10.3390/nu13072211 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Wu P-W, Tsai S, Lee C-Y, et al. Contribution of insulin resistance to the relationship between sugar-sweetened beverage intake and a constellation of cardiometabolic abnormalities in adolescents. Int J Obesity. 2021;45(4):828–839. doi: 10.1038/s41366-021-00745-1 [DOI] [PubMed] [Google Scholar]
  • 19.Zeng X, Y-j X, Y-t L, S-l L, Z-c M. Polycystic ovarian syndrome: correlation between hyperandrogenism, insulin resistance and obesity. Clin Chim Acta. 2020;502:214–221. doi: 10.1016/j.cca.2019.11.003 [DOI] [PubMed] [Google Scholar]
  • 20.Grimes CA, Bolton KA, Booth AB, Khokhar D, He FH, Nowson CA. The association between dietary sodium intake, adiposity and sugar-sweetened beverages in children and adults: a systematic review and meta-analysis. Br J Nutr. 2021;126(3):409–427. doi: 10.1017/S0007114520004122 [DOI] [PubMed] [Google Scholar]
  • 21.Lin AW, Siscovick D, Sternfeld B, et al. Associations of diet, physical activity and polycystic ovary syndrome in the coronary artery risk development in young adults women’s study. BMC Public Health. 2021;21(1):35. doi: 10.1186/s12889-020-10028-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Alomran S, Estrella ED. Effect of dietary regimen on the development of polycystic ovary syndrome: a narrative review. Cureus. 2023;15(10):e47569. doi: 10.7759/cureus.47569 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Begum RF, Singh SA, Mohan S. Impact of junk food on obesity and polycystic ovarian syndrome: mechanisms and management strategies. Obesity Med. 2023;40:100495. doi: 10.1016/j.obmed.2023.100495 [DOI] [Google Scholar]
  • 24.Emanuele MA, Wezeman F, Emanuele NV. Alcohol’s effects on female reproductive function. Alcohol Res Health. 2002;26(4):274–281. [PMC free article] [PubMed] [Google Scholar]
  • 25.Finn DA. The endocrine system and alcohol drinking in females. Alcohol Research. 2020;40(2):02. doi: 10.35946/arcr.v40.2.02 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Carr RM, Dhir R, Yin X, Agarwal B, Ahima RS. Temporal effects of ethanol consumption on energy homeostasis, hepatic steatosis, and insulin sensitivity in mice. Alcoholism Clin Experi Res. 2013;37(7):1091–1099. doi: 10.1111/acer.12075 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Tin ST, Smith-Byrne K, Ferrari P, et al. Alcohol intake and endogenous sex hormones in women: meta-analysis of cohort studies and Mendelian randomization. Res Square. 2023. doi: 10.21203/rs.3.rs-3249588/v1 [DOI] [PubMed] [Google Scholar]
  • 28.Tehrani HG, Allahdadian M, Zarre F, Ranjbar H, Allahdadian F. Effect of green tea on metabolic and hormonal aspect of polycystic ovarian syndrome in overweight and obese women suffering from polycystic ovarian syndrome: a clinical trial. J Educat Health Promot. 2017;6:36. doi: 10.4103/jehp.jehp_67_15 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Maleki V, Taheri E, Varshosaz P, et al. A comprehensive insight into effects of green tea extract in polycystic ovary syndrome: a systematic review. Reprod Biol Endocrinol. 2021;19(1):147. doi: 10.1186/s12958-021-00831-z [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Power GM, Sanderson E, Pagoni P, et al. Methodological approaches, challenges, and opportunities in the application of Mendelian randomisation to lifecourse epidemiology: a systematic literature review. Eur j epidemiol. 2023;38(1):1–20. doi: 10.1007/s10654-022-00941-x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Emdin CA, Khera AV, Kathiresan S. Mendelian Randomization. JAMA. 2017;318(19):1925–1926. doi: 10.1001/jama.2017.17219 [DOI] [PubMed] [Google Scholar]
  • 32.Tyrmi JS, Arffman RK, Pujol-Gualdo N, et al. Leveraging Northern European population history: novel low-frequency variants for polycystic ovary syndrome. Hum Reprod. 2022;37(2):352–365. doi: 10.1093/humrep/deab250 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Kurki MI, Karjalainen J, Palta P, et al. FinnGen provides genetic insights from a well-phenotyped isolated population. Nature. 2023;613(7944):508–518. doi: 10.1038/s41586-022-05473-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Sudlow C, Gallacher J, Allen N, et al. UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLoS Med. 2015;12(3):e1001779. doi: 10.1371/journal.pmed.1001779 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Machiela MJ, Chanock SJ. LDlink: a web-based application for exploring population-specific haplotype structure and linking correlated alleles of possible functional variants. Bioinformatics. 2015;31(21):3555–3557. doi: 10.1093/bioinformatics/btv402 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Burgess S, Small DS, Thompson SG. A review of instrumental variable estimators for Mendelian randomization. Stat Methods Med Res. 2017;26(5):2333–2355. doi: 10.1177/0962280215597579 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Cao Z, Wu Y, Li Q, Li Y, Wu J. A causal relationship between childhood obesity and risk of osteoarthritis: results from a two-sample Mendelian randomization analysis. Ann Med. 2022;54(1):1636–1645. doi: 10.1080/07853890.2022.2085883 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Chen X, Hong X, Gao W, et al. Causal relationship between physical activity, leisure sedentary behaviors and COVID-19 risk: a Mendelian randomization study. J Transl Med. 2022;20(1):216. doi: 10.1186/s12967-022-03407-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Wu F, Huang Y, Hu J, Shao Z. Mendelian randomization study of inflammatory bowel disease and bone mineral density. BMC Med. 2020;18(1):312. doi: 10.1186/s12916-020-01778-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Burgess S, Thompson SG. Interpreting findings from Mendelian randomization using the MR-Egger method. Eur J Epidemiol. 2017;32(5):377–389. doi: 10.1007/s10654-017-0255-x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Yin KJ, Huang JX, Wang P, et al. No genetic causal association between periodontitis and arthritis: a bidirectional two-sample mendelian randomization analysis. Front Immunol. 2022;13:808832. doi: 10.3389/fimmu.2022.808832 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Chavarro JE, Rich-Edwards JW, Rosner BA, Willett WC. Caffeinated and alcoholic beverage intake in relation to ovulatory disorder infertility. Epidemiology. 2009;20(3):374–381. doi: 10.1097/EDE.0b013e31819d68cc [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Bahri Khomami M, Teede HJ, Joham AE, Moran LJ, Piltonen TT, Boyle JA. Clinical management of pregnancy in women with polycystic ovary syndrome: an expert opinion. Clin Endocrinol. 2022;97(2):227–236. doi: 10.1111/cen.14723 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Rachdaoui N, Sarkar DK. Pathophysiology of the Effects of Alcohol Abuse on the Endocrine System. Alcohol Research. 2017;38(2):255–276. doi: 10.35946/arcr.v38.2.08 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Hernández-Rubio A, Sanvisens A, Bolao F, et al. Prevalence and associations of metabolic syndrome in patients with alcohol use disorder. Sci Rep. 2022;12(1):2625. doi: 10.1038/s41598-022-06010-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Kim SK, Hong SH, Chung JH, Cho KB. Association between alcohol consumption and metabolic syndrome in a community-based cohort of Korean adults. Med Sci Monitor. 2017;23:2104–2110. doi: 10.12659/MSM.901309 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Lim SS, Kakoly NS, Tan JWJ, et al. Metabolic syndrome in polycystic ovary syndrome: a systematic review, meta-analysis and meta-regression. Obesity Rev. 2019;20(2):339–352. doi: 10.1111/obr.12762 [DOI] [PubMed] [Google Scholar]
  • 48.Åberg F, Byrne CD, Pirola CJ, Männistö V, Sookoian S. Alcohol consumption and metabolic syndrome: clinical and epidemiological impact on liver disease. J Hepatol. 2023;78(1):191–206. doi: 10.1016/j.jhep.2022.08.030 [DOI] [PubMed] [Google Scholar]
  • 49.Genchi VA, Cignarelli A, Sansone A, et al. Understanding the role of alcohol in metabolic dysfunction and male infertility. Metabolites. 2024;14(11):626. doi: 10.3390/metabo14110626 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Cederbaum AI. Alcohol metabolism. Clin Liver Dis. 2012;16(4):667–685. doi: 10.1016/j.cld.2012.08.002 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Liu SY, Tsai IT, Hsu YC. Alcohol-Related liver disease: basic mechanisms and clinical perspectives. Int J Mol Sci. 2021;22(10). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Yan C, Hu W, Tu J, Li J, Liang Q, Han S. Pathogenic mechanisms and regulatory factors involved in alcoholic liver disease. J Transl Med. 2023;21(1):300. doi: 10.1186/s12967-023-04166-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Wang Y, Yang Y, Deng H, et al. Coffee consumption and the risk of polycystic ovary syndrome: evidence from a case-control study. 2021.
  • 54.Maldonado-Cárceles AB, Mitsunami M, Florio A, et al. Beverage intake and ovarian reserve among women from a fertility center. Fertil Sterility. 2022;118(1):148–157. doi: 10.1016/j.fertnstert.2022.03.016 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Kshetrimayum C, Sharma A, Mishra VV, Kumar S. Polycystic ovarian syndrome: environmental/occupational, lifestyle factors; an overview. J Turkish German Gynecol Assoc. 2019;20(4):255. doi: 10.4274/jtgga.galenos.2019.2018.0142 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.DiNicolantonio JJ, O’Keefe JH. Added sugars drive insulin resistance, hyperinsulinemia, hypertension, type 2 diabetes and coronary heart disease. Missouri Med. 2022;119(6):519–523. [PMC free article] [PubMed] [Google Scholar]
  • 57.Shen W, Pan Y, Jin B, et al. Effects of tea consumption on anthropometric parameters, metabolic indexes and hormone levels of women with polycystic ovarian syndrome: a systematic review and meta-analysis of randomized controlled trials. Front Endocrinol. 2021;12:736867. doi: 10.3389/fendo.2021.736867 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Colonetti L, Grande AJ, Toreti IR, Ceretta LB, Da Rosa MI, Colonetti T. Green tea promotes weight loss in women with polycystic ovary syndrome: systematic review and meta-analysis. Nutr res. 2022;104:1–9. doi: 10.1016/j.nutres.2022.03.009 [DOI] [PubMed] [Google Scholar]
  • 59.Farhud DD. Hypothetical strategies of gene and environmental influence on life expectancy: a brief review. Iran J Public Health. 2022;51(11):2382–2387. doi: 10.18502/ijph.v51i11.11156 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Klimek P, Aichberger S, Thurner S. Disentangling genetic and environmental risk factors for individual diseases from multiplex comorbidity networks. Sci Rep. 2016;6:39658. doi: 10.1038/srep39658 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Rodrigues AMDS, Martins LB, Franklin AMT, Candido AL, Santos LCD, Ferreira AVM. Poor quality diet is associated with overweight status and obesity in patients with polycystic ovary syndrome. J Hum Nutr Diet. 2015;28:94–101. doi: 10.1111/jhn.12205 [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

All data generated or analyzed during this study are included in this article and supplementary information files.


Articles from International Journal of Women's Health are provided here courtesy of Dove Press

RESOURCES